Price Alert

GlycoMimetics Inc. (GLYC)

NASDAQ: GLYC · Real-Time Price · USD

15.71

-0.44 (-2.72%)

At close: Jul 02, 2025, 3:58 PM

GlycoMimetics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	Q2 2025	Q1 2025	Q4 2024	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023	Q1 2023	Q4 2022	Q3 2022	Q2 2022	Q1 2022	Q4 2021	Q3 2021	Q2 2021	Q1 2021
Period Ending	Jun 30, 2025	Mar 31, 2025	Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021
Cash & Equivalents	152.65M	5.61M	10.72M	14.39M	22.39M	31.28M	41.79M	49.41M	58.04M	65M	47.87M	51.62M	60.24M	76.52M	90.25M	101.92M	118.85M	132.47M
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Assets	1.41M	n/a	n/a	52.32K	137.1K	339.26K	757.91K	102.32M	102.32K	102.32K	102.32K	860.12K	2.27M	2.27M	2.15M	1.61M	1.61M	1.61M
Receivables	n/a	n/a	136.58K	50.26K	76.71K	109.95K	175.82K	188.95K	215.37K	234.11K	144.02K	90.33K	120.87K	4.78K	1.35K	1.44K	1.66K	444.57K
Inventory	n/a	n/a	n/a	n/a	n/a	n/a	n/a	49.36B	-2.33B	-3.08B	-144.4K	n/a	n/a	n/a	-535.15K	n/a	n/a	n/a
Other Current Assets	1.58M	78.76K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Assets	154.23M	5.99M	11.09M	15.65M	23.86M	33.27M	43.79M	52.01B	60.37M	68.09M	50.71M	53.85M	61.26M	77.46M	90.25M	104.13M	120.31M	133.71M
Property-Plant & Equipment	1.8M	n/a	n/a	n/a	424.21K	598.26K	767.83K	1.09B	1.35M	732.8K	993.56K	1.25M	1.51M	1.73M	1.95M	2.2M	2.45M	2.7M
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	3.21M	n/a	n/a	52.32K	561.31K	937.52K	1.53M	1.19B	1.45M	835.12K	1.1M	2.11M	3.78M	4M	4.09M	3.81M	4.06M	4.31M
Total Assets	157.43M	5.99M	11.09M	15.7M	24.42M	34.2M	45.32M	53.2M	61.82M	68.92M	51.81M	55.96M	65.04M	81.46M	94.35M	107.94M	124.38M	138.02M
Account Payables	1.65M	148.26K	329.3K	581.79K	950.76K	755.53K	868.12K	329.88K	241.49K	480.15K	970.19K	852.13K	1.27M	2.28M	2.11M	1.39M	1.17M	2.14M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-5.5B	n/a	n/a	n/a	n/a	n/a	918.61K	n/a	n/a	n/a
Short-Term Debt	211K	n/a	66.84K	262.13K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Current Liabilities	16.54M	1.68M	4.47M	1.98M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Liabilities	16.75M	2.62M	5.78M	4.32M	4.36M	5.29M	6.84M	6.39B	6.57M	6.74M	8.88M	7.75M	8.94M	12.78M	11.82M	9.66M	10.25M	10.84M
Long-Term Debt	1.43M	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	538.59K	408.32K	373.91K
Total Long-Term Liabilities	1.43M	n/a	n/a	n/a	n/a	n/a	66.84K	262.13M	448.77K	1.13B	1.89M	95.61K	378.79K	651.79K	918.61K	1.72M	1.84M	2.05M
Total Liabilities	18.18M	2.62M	5.78M	4.32M	4.36M	5.29M	6.9M	6.65M	7.02M	6.74M	8.88M	7.84M	9.32M	13.43M	12.74M	11.38M	12.09M	12.9M
Total Debt	1.64M	n/a	66.84K	262.13K	448.77K	630.83K	808.4K	1.01B	1.27M	651.73K	918.55K	1.18M	1.43M	1.68M	1.92M	2.15M	2.38M	2.6M
Common Stock	14K	64.53K	64.48K	64.48K	64.48K	64.45K	64.39K	64.37M	64.31K	64.25K	54.38K	52.42K	52.42K	52.39K	52.31K	51.74K	51.54K	51.54K
Retained Earnings	-54.8M	-496.71M	-494.36M	-487.14M	-477.32M	-467.22M	-456.49M	-447.41B	-438.2M	-429.95M	-419.59M	-409.34M	-400.82M	-387.55M	-372.9M	-355.48M	-338.14M	-323.74M
Comprehensive Income	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-0.00	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	-2.19M	-2.13M
Shareholders Equity	139.25M	3.38M	5.31M	11.38M	20.06M	28.91M	38.41M	46.55M	54.8M	62.18M	42.93M	48.12M	55.73M	68.03M	81.6M	96.57M	112.29M	125.12M
Total Investments	n/a	n/a	n/a	14.38B	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a